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Cry1Ab toxin binding analysis was performed to determine whether resistance in laboratory-selected Os-
trinia nubilalis strains is associated with target site alteration. Brush border membrane vesicles were prepared
using dissected midguts from late instars of susceptible and resistant strains (Europe-R and RSTT) of O.
nubilalis. Immunoblot analysis indicated that three different proteins bound to Cry1Ab toxin and were recog-
nized by an anticadherin serum. In a comparison of resistant and susceptible strains, reduced Cry1Ab binding
was apparent for all three bands corresponding to cadherin-like proteins in the Europe-R strain, while reduced
binding was apparent in only one band for the RSTT strain. Real-time analysis of Cry1Ab binding to gut
receptors using surface plasmon resonance suggested slight differences in affinity in both resistant strains.
Additional binding analysis was conducted using 125I-labeled Cry1Ab, Cry1Ac, and Cry1Aa. Slight differences
were again observed between the resistant and susceptible strains for Cry1Ab binding. However, when binding
of 125I-labeled Cry1Aa was tested, a 10-fold reduction in the concentration of binding sites was observed in the
Europe-R strain. Expression of the O. nubilalis cadherin gene was similar in both the resistant and susceptible
strains and did not account for differences in binding. In combination, the results of the present work suggest
that differences in susceptibility to Cry1A toxins in the Europe-R strain of O. nubilalis are associated with
altered receptor binding, although the precise nature of this mechanism is still uncertain.
Lepidopteran insects are particularly susceptible to Cry1
toxins from Bacillus thuringiensis (Berliner) (Bt toxins), which
are highly toxic after ingestion. They are solubilized and enzy-
matically processed by proteinases present in the insect midgut
to an active protein core. Active toxins bind specifically to
midgut receptors, causing the formation of lytic pores after
toxin conformational change and insertion into the membrane
(11, 23, 36, 38) and, ultimately, death. Although this general
process is widely accepted, details on the intoxication process,
such as postbinding events and receptor specificity, are still
unclear (12, 48).
Despite their effectiveness for over half a century, resistance
development to Bt-based insecticides has become a growing pub-
lic concern, particularly with regard to transgenic crops that ex-
press Bt toxins. To prevent or at least delay resistance and sustain
this new technology, deployment strategies are being developed
that minimize selective pressures or reduce the selective advan-
tage of resistance genes. Although a number of species have been
successfully selected in the laboratory for resistance to Bt toxins
(reviewed by Ferré and Van Rie [8]), high levels of resistance to
Bt toxins and cross-resistance in the field have been reported only
in Plutella xylostella (8, 43) and in glasshouse populations of
Trichoplusia ni (19). In most cases, the mechanism of resistance
has been proposed to involve altered toxin binding to specific
receptors in the insect midgut (8, 49).
Changes in receptor conformation that interfere with toxin
binding through substitution or loss of amino acids represent the
most likely mechanism of resistance to Bt toxins (17). However,
conclusive evidence is generally lacking to support such a mech-
anism. Recently, however, disruption of a cadherin superfamily
gene by retrotransposon-mediated insertion has been linked to
high levels of resistance to Cry1Ac in Heliothis virescens (10). The
predicted amino acid sequence from the resistant gene does not
possess the trans-membrane or toxin binding domains, which
would prevent binding and confer high levels of resistance. In
other research with this species, altered glycosylation of microvil-
lus proteins has been associated with reduced toxin binding and
pore formation as well as increased resistance to Cry1 toxins (21).
In the pink bollworm, Pectinophora gossypiella, three cadherin-
like alleles were associated with resistance to Cry1Ac and con-
ferred survival to transgenic Bt cotton (34).
The European corn borer, Ostrinia nubilalis (Hübner), is a
significant pest of corn throughout North America (31). Since its
initial introduction in 1996, transgenic Bt corn has increased in
popularity among growers for managing corn borer infestations.
Resistance to B. thuringiensis subsp. kurstaki in O. nubilalis has
been reported in laboratory-selected strains exposed to the Bt
formulation Dipel ES (18) and to the isolated Cry1Ac (3) and
Cry1Ab (5, 39) toxins. A resistance mechanism has been partially
characterized only in the Dipel-selected strain, in which differ-
ences in midgut proteases were linked to resistance (26, 29).
We have selected O. nubilalis laboratory strains for resis-
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tance to Cry1Ab protoxin and observed significant levels of
resistance to this toxin and cross-resistance to Cry1Ac after 7
to 10 generations (5, 39). Resistance to Cry1Ab-activated toxin
in these strains was at least 100-fold (40) after 40 generations
of selection. Comparisons of midgut protease activities be-
tween resistant and susceptible strains revealed no consistent
differences (40). This observation, along with the narrow cross-
resistance pattern, suggested that resistance in these selected
strains of O. nubilalis may involve modified midgut receptors.
Therefore, the objective of the present study was to determine
if altered binding is associated with Cry1Ab resistance in se-
lected O. nubilalis strains.
MATERIALS AND METHODS
O. nubilalis strains. Populations of O. nubilalis designated Europe-S, Eu-
rope-R, and RSTT-R were established as laboratory strains. The European
strain was established in 1993 from approximately 500 O. nubilalis larvae col-
lected in the Lombardia region of northern Italy and was provided to the
University of Nebraska after 20 generations of laboratory rearing. This strain was
divided into two subpopulations, one exposed throughout development to
Cry1Ab protoxin from the B. thuringiensis subsp. kurstaki strain HD1-9, which
produces only Cry1Ab protein (Europe-R), and the other reared in the absence
of protoxin (Europe-S). The RSTT-R strain resulted from a combination of
individuals from the Europe-R selection line and from a selection line from
insects collected in Nebraska (39). All the resistant strains were selected with
Cry1Ab protoxin.
Toxin preparation. For radioligand binding, Cry1Aa, Cry1Ab, and Cry1Ac
protoxins were obtained from recombinant B. thuringiensis EG1273, EG7077,
and EG11070 strains, respectively (Ecogen Inc., Langhorn, PA). Each B. thurin-
giensis strain was grown at 29°C for 48 h in CCY medium (42) supplemented with
10 g/ml of tetracycline for strains EG1273 and EG7077 and 3 g/ml of chlor-
amphenicol for strain EG11070. Spores and crystals were collected by centrifu-
gation at 9,700  g at 4°C for 10 min. Pellets were washed four times with 1 M
NaCl–10 mM EDTA and suspended in 10 mM KCl. Crystals were solubilized in
50 mM sodium carbonate buffer (pH 10.5) containing 10 mM dithiothreitol.
Protoxins were trypsin activated (trypsin type XI from bovine pancreas; Sigma
Chemical Co., St. Louis, MO) at 37°C, 2 h (1 mg trypsin per 10 mg of protoxin).
Finally, activated toxins were purified by anion-exchange chromatography as
described by Estela et al. (7). The protein concentration in the preparations of Bt
toxins was measured by the method of Bradford (4) using the Bio-Rad protein
assay (Bio-Rad Laboratories GmgH, Munchen, Germany), with bovine serum
albumin (BSA) as a protein standard.
The trypsin-activated Cry1Ab toxin used for immunoblotting and real-time
binding kinetics was provided by Monsanto Co. (St. Louis, MO). The Cry1Ab
protoxin was treated with bovine pancreatic trypsin and purified in a 1.2-liter Q
Sepharose Fast Flow column. The trypsin-resistant core protein was eluted as a
single symmetrical peak by using a gradient of sodium chloride. Peak tubes were
pooled and dialyzed against 50 mM carbonate/bicarbonate buffer, pH 10.25, with
50 mM sodium chloride. The activated Cry1Ab protein was recovered at 94%
purity.
BBMV preparation. Brush border membrane vesicles (BBMV) were prepared
with gut tissue dissected from ice-chilled early fifth-instar larvae. The midguts
were pulled gently from the larvae after both the last three abdominal segments
and the head plus thorax were removed. A small glass culture tube was rolled
over the length of the gut to displace the gut contents. Dissected gut tissue was
transferred to a centrifuge tube containing ice-cold MET buffer (300 mM man-
nitol, 17 mM Tris-HCl pH 7.5, 5 mM EGTA, protease inhibitor [Complete
EDTA-free protease inhibitors cocktail; Roche Applied Science, Indianapolis,
IN]), vigorously vortexed, and briefly centrifuged for 5 min at 1,000 g to obtain
the clean midguts. Guts were either frozen at 80°C or processed immediately
by the differential magnesium precipitation method of Wolfersberger et al. (46).
Briefly, gut tissues were homogenized on ice in a tight-fitting glass Dounce
homogenizer in ice-cold MET buffer (10%, wt/vol). The homogenate was diluted
with an equal volume of ice-cold 24 mM MgCl2, blended, and held on ice for 15
min before centrifugation. A low-speed centrifugation (2,500  g for 15 min at
4°C) was used to pellet heavier cell debris, and the supernatant from the initial
centrifugation was further centrifuged at 30,000  g for 30 min at 4°C. The
resulting pellet was resuspended in MET buffer and centrifuged again at 2,500 
g and then at 30,000  g for 30 min at 4°C. The resulting pellet, which corre-
sponded to the BBMV preparation, was resuspended in HBS-N buffer (10 mM
HEPES, pH 7.4, 150 mM NaCl), flash-frozen in liquid nitrogen, and stored at
80°C until use. The protein concentration of the BBMV preparations was
determined by the bicinchoninic acid method (41). Alkaline phosphatase and
aminopeptidase activities were used as marker enzymes to track purification of
the BBMV preparation and were 8 to 12 times higher in BBMV preparations
than in the initial homogenates (data not shown).
To prepare BBMV for radioligand binding analysis, fifth-instar larvae were
collected, frozen in liquid nitrogen, preserved in dry ice, and sent to the Uni-
versity of Valencia in Spain. Upon arrival, larvae were dissected in ice-cold MET
buffer without protease inhibitors. BBMV were prepared essentially as above,
and the pellet corresponding to BBMV was suspended in 0.5 MET buffer.
Immunoblotting. Western blot assays of Cry1Ab binding to BBMV proteins
were performed using a chemiluminescence Western Light kit (Tropix, Inc.,
Bedford, MA). Equal amounts (80 g) of BBMV protein from each strain were
separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis as
described by Laemmli (24), electroblotted onto a polyvinylidene difluoride
(PVDF) membrane (Bio-Rad Inc., Hercules, CA) for 90 min by using a Mini
Trans-Blot electrophoretic transfer cell (Bio-Rad, Hercules, CA), and blocked
for 2 h at room temperature with phosphate-buffered saline (PBS; pH 8.0)
containing 5% nonfat dry milk powder, 5% glycerol, 0.5% Tween 20 (freshly
made). The PVDF membrane was then incubated with activated Cry1Ab (250
ng/ml) in blocking buffer overnight at 4°C and subsequently washed three times
with blocking buffer. The blot was then incubated with polyclonal rabbit anti-
Cry1Ab (1:2,500; provided by Monsanto Co., St. Louis, MO), washed three
times, incubated with goat anti-rabbit–alkaline phosphatase (secondary antibody
at 1:10,000), and washed three times with blocking buffer. The PVDF membrane
was washed with assay buffer (Tropix Inc., Bedford, MA), and detection was
performed with the CDP-Star chemiluminescence kit (Tropix Inc., Bedford,
MA) using a fluorescence imager (Fluor-S Imager; Bio-Rad, Hercules, CA).
Western blot assays for cadherin-like proteins were performed as described
above, except that a polyclonal anticadherin serum (1:3,000 at room temperature
for 1 h; provided by Pioneer Hi-Bred International, Johnston, IA) developed
from a 1.8-kb region of the O. nubilalis cadherin-like gene, which included the
cadherin repeats 10, 11, and 12 of the protein, was used. The membrane was
washed as described above, and an anti-rabbit–alkaline phosphatase serum con-
jugate (1:10,000 at room temperature for 1 h) was applied to the PVDF mem-
brane. After repeated washings with assay buffer (Tropix Inc., Bedford, MA), the
membrane was incubated with CDP-Star for 5 min and the image was captured
as described above.
Real-time binding kinetics. Small unilamellar vesicles (SUV) were prepared
from O. nubilalis BBMV in HBS-N buffer by extrusion (30). Briefly, BBMV
proteins were diluted to a concentration of 0.5 mg/ml, homogenized, and passed
four times through a 400-nm polycarbonate filter (Avestin, Inc., Ottawa, Canada)
in a Liposofast Basic extrusion apparatus (Avestin, Inc., Ottawa, Canada). The
resulting liposome solution was subsequently passed four times through a
100-nm polycarbonate filter and finally passed 12 times through a 50-nm poly-
carbonate filter to give a translucent solution. Samples were aliquoted to 50 l,
frozen in liquid nitrogen, and stored at 80°C until use.
The surface plasmon resonance (SPR) detector (BIAcore 2000 system) and
sensor chips (Pioneer L1) were purchased from BIAcore Inc. (Piscataway, NJ).
The running and diluting buffer in all experiments was HBS-N. The methods for
SPR analysis of Cry1Ab binding to O. nubilalis SUV were based on those
described by Masson et al. (32, 33) and Cooper et al. (6). All the experiments
were performed at 25°C, and the L1 chip was conditioned with two short pulses
of detergent solution (40 mM n-octyl--D-glucopyranoside, 0.1 M NaOH) at 100
l/min prior to attachment of SUV. Vesicles (0.5 mg/ml) were immobilized onto
the lipophilic-modified dextran surface of the chip. Approximately 1,000 reso-
nance units were reproducibly captured onto the chip surface after a short pulse
(1 min) with NaOH (10 mM) at 30 l/min to create more stability in the vesicle
surface. This immobilization level was the minimum necessary to initiate analyte
binding in these analyses. The vesicle surface was subsequently blocked with a
5-min pulse of BSA (0.1 mg/ml) and held until a stable baseline was obtained.
For real-time analysis using SPR, the activated Cry1Ab toxin was dialyzed
against HBS-N (10 mM HEPES, pH 7.4, 150 mM NaCl) overnight at 4°C and
then centrifuged at 16,000  g for 10 min. The pooled supernatant was analyzed
using a bicinchoninic acid assay to determine the protein concentration (41).
Binding kinetics analysis was performed by injecting activated Cry1Ab toxin at
30 l/min for 200 s, followed by a 300-s dissociation phase. Cry1Ab (dissolved in
HBS-N) concentrations varied from 100 nM up to 1,000 nM for the susceptible
strain and from 500 nM up to 1,750 nM for resistant strains. At the end of each
experiment, the chip surface was regenerated with two pulses of detergent
solution (40 mM n-octyl--D-glucopyranoside, 0.1 M NaOH). A reference flow
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cell without BBMV immobilization was used in all experiments to avoid bulk
effects (the SPR response caused by the difference in bulk refractive index
between the sample and the running buffer). The experimentation was per-
formed at least three times with two samples for each colony.
All sensorgram data were analyzed with the BIAevaluation software version
3.0 (BIAcore Inc., Piscataway NJ), by local fitting. The software directly gener-
ated parameters for a simple binding model of one analyte to one ligand. The
model equation to describe the interaction can be written as dR/dt  konC(Rmax 
Rt)  koffRt, where R is the response, dR/dt is the rate of toxin-receptor complex
formation, C is the concentration of injected toxin, Rmax  Rt is the amount of
free remaining receptor sites at time t (expressed in resonance units), kon is the
association rate constant (expressed as M1 s1), and koff is the dissociation rate
constant (expressed as s1) (22). All models were evaluated for goodness of fit
of the data to the Lingmuir (1:1) model for both association and dissociation rate
constants based on a chi-square value of 10.0. Models were also verified by
residual plots, which calculated the differences between the observed and the
fitted curves for each data point.
125I labeling and binding assays. Trypsin-activated Cry1Aa, Cry1Ab, and
Cry1Ac were labeled with 125I by the method of chloramine-T as previously
described (45). The specific radioactivities were 9.22 mCi/mg, 5.11 mCi/mg, and
110 mCi/mg for labeled Cry1Aa, Cry1Ab, and Cry1Ac, respectively. To deter-
mine the appropriate concentration of BBMV for competition assays, vesicles
from each strain (0 to 0.25 mg of total vesicle protein/ml) were incubated with 81
pM [125I]Cry1Aa, 67 pM [125I]Cry1Ab, or 3 pM [125I]Cry1Ac in 100 l of PBS
(pH 7.4) containing 0.1% BSA (PBS-BSA) at room temperature for 60 min. The
toxin bound to BBMV was separated from free toxin by centrifugation at
16,000g at 4°C for 10 min. The pellet was washed twice with 500 l of ice-cold
PBS-BSA. The radioactivity in the pellet was then measured in a 1282 Compu-
gamma CS Universal gamma counter (LKB Wallac Pharmacia, Turku, Finland)
and taken as total binding. Nonspecific binding was estimated by adding a
10,000-fold excess of unlabeled toxin to the reaction mixture. Specific binding
was calculated as the difference between total and nonspecific binding.
For competition assays, increasing amounts of unlabeled Cry1Aa, Cry1Ab, or
Cry1Ac toxins were added to the reaction mixture containing each labeled toxin
and 100 g/ml BBMV in PBS-BSA for the experiments performed with labeled
Cry1Aa or 50 g/ml for the experiments performed with labeled Cry1Ab and
Cry1Ac. The equilibrium dissociation constant (Kd) and binding site concentra-
tion (Rt) were estimated with the LIGAND software (35). Statistical tests (anal-
ysis of variance) were performed and charts were made using GraphPad Prism
version 4.02 for Windows (GraphPad Software, San Diego, CA.). All binding
experiments were independently performed at least twice.
Total RNA and mRNA extraction from gut tissue and Northern blotting.
Fourth-instar O. nubilalis larvae were used for dissection of gut tissue as de-
scribed previously. Dissected guts were frozen in liquid nitrogen until further
processing. Total RNA was isolated using the TRIzol reagent (Sigma, St. Louis,
MO). Approximately 70 mg of tissue from each strain was ground in liquid
nitrogen and quickly processed with TRIzol according to the manufacturer’s
instructions (Sigma, St. Louis, MO) to generate total RNA. Extracted RNA was
diluted in Tris-HCl buffer (5 mM, pH 8.0), quantified spectrophotometrically
using the absorbance ratio of 1.8 at 260/280 nm, and stored at 80°C until
further use.
Fresh total RNA obtained as described above from O. nubilalis gut tissue was
used for Northern blotting analysis. A cDNA probe (700 bp) was generated using
primers (Fw, 5	-CCCACATTTTCATCATCGTC-3	; Rv, 5	-CATCCTCCAGTT
CTATCACC-3	) designed from the O. nubilalis cadherin gene (GenBank acces-
sion number AX147207). The probe was labeled with digoxigenin (DIG) using
the DIG PCR labeling kit (Roche Applied Science, Indianapolis, IN). Samples of
total RNA (7.5 g) from resistant and susceptible strains were separated by
denaturing electrophoresis on a 1.2% agarose–formaldehyde gel. The RNAs
were transferred overnight onto positively charged nylon membranes (Roche
Applied Science, Indianapolis, IN) by capillary blotting using diethyl pyrocar-
bonate-treated 20 SSC transfer buffer (3.0 M NaCl, 0.3 M sodium citrate, pH
7.0) and irreversibly fixed in a baking oven at 80°C for 2 h. The blot was
prehybridized for 1 h at 50°C in 5 ml of hybridization solution (DIG Easy hyb;
Roche Applied Science, Indianapolis, IN). After adding the denatured probe to
a fresh hybridization solution, the membrane was hybridized overnight at 50°C
with continuous shaking. The blot was rinsed three times with continuous shak-
ing in 2 SSC, 0.1% SDS at room temperature and three times with 0.5 SSC,
0.1% SDS at 68°C to eliminate nonspecific hybridizations. The membrane was
washed briefly in washing buffer (maleate buffer, 0.3% Tween 20), blocked for
1 h in 0.5 blocking buffer (Roche Applied Science, Indianapolis, IN), and then
incubated with anti-DIG at a 1:15,000 dilution in blocking buffer for 45 min. The
membrane was washed four times (15 min each) with washing buffer, briefly
washed with detection buffer (Roche Applied Science, Indianapolis, IN) for 5
min, and incubated with the chemiluminescent substrate for alkaline phos-
phatase (CSPD; Tropix Inc., Bedford, MA) for 5 min. The blot was exposed to
chemiluminescence Biomax film (Kodak, Rochester, NY) at room temperature
for 25 min. The membrane was stripped and reprobed with the O. nubilalis
DIG-labeled RPS3 probe (600 bp) to standardize loadings.
RESULTS
Immunoblot assays. Immunoblot assays to identify potential
Cry1Ab binding proteins using both anti-Cry1Ab and anti-
OnBt-R1 serum are presented in Fig. 1. Signals from both
Cry1Ab ligand blotting and the anticadherin Western blotting
were compared among the susceptible and resistant strains. The
Cry1Ab toxin bound more strongly to the 220-kDa band than the
170-kDa and 160-kDa bands (Fig. 1, lane 4) in the susceptible
strain, based on signal intensities. A similar pattern was observed
in the Western blot assay using the O. nubilalis anticadherin
serum, with the 220-kDa band showing the strongest signal in the
susceptible strain (Fig. 1, lane 1). Similar Cry1Ab binding proteins
were observed in the two resistant strains; however, signal inten-
sity was considerably reduced in the Europe-R strain compared to
the susceptible strain (Fig. 1, lane 5) for all three bands. Reduc-
tion in signal intensity was also observed in this strain when the
membrane was probed with the anticadherin serum (Fig. 1, lane
2). The 220-kDa protein was the only band clearly visible in the
Europe-R strain for both Cry1Ab and anticadherin binding. The
RSTT-R strain showed clearly reduced binding of the 160-kDa
protein and a slight reduction of binding for the 220-kDa and
170-kDa proteins for both Cry1Ab and anticadherin serum. No
bands were visible in the controls performed without Cry1Ab and
anticadherin serum (data not shown).
Real-time binding kinetics. Cry1Ab binding to O. nubilalis
SUV preparations as measured by SPR and differences in
binding among strains are documented in the sensorgrams
presented in Fig. 2. Kinetics analysis and affinity constants
determined for susceptible and resistant strains are presented
in Table 1. Significant differences were observed in the Cry1Ab
FIG. 1. Binding of anticadherin (anti-OnBt-R1) from O. nubilalis
and Cry1Ab toxin to BBMV proteins (80 g) from one susceptible
and two Cry1Ab-selected strains. Lanes: 1 and 4, Europe-S; 2 and 5,
Europe-R; 3 and 6, RSTT-R. Cry1Ab toxin was detected using a
specific antibody against it.
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association rates (kon) between Europe-S and both resistant
strains, whereas the RSTT-R strain exhibited higher rates of
Cry1Ab dissociation (koff) relative to both Europe-S and Eu-
rope-R. Overall, significant differences existed in equilibrium
dissociation constants (Kd) between the Europe-S strain (35 

3 nM) and resistant Europe-R (61 
 6 nM) and RSTT-R (94 

11 nM) strains, conferring at least a twofold lower Cry1Ab
binding affinity in both resistant strains.
Binding with 125I-labeled toxins. Experiments performed to
determine the appropriate amount of BBMV to use in com-
petition binding assays showed that Cry1Aa, Cry1Ab, and
Cry1Ac bound specifically to BBMV from both susceptible
and resistant larvae (Fig. 3). The results showed that labeled
Cry1Aa reached a much lower level of maximum binding (4%)
in the Europe-R strain than the Europe-S or RSTT-R strains
(9%) (Fig. 3A). In contrast, assays performed with labeled
Cry1Ab and Cry1Ac showed that the maximum binding of
these toxins was similar among strains (Fig. 3B and C).
Homologous competition binding experiments (when bind-
ing of a labeled ligand is competed with the same unlabeled
ligand) were performed to obtain quantitative data on binding
parameters. Assays performed with labeled Cry1Aa showed a
main difference in Europe-R compared to the other two strains
(Fig. 4A). Quantitative analysis of the data revealed a 10-fold
decrease in concentration of binding sites (Rt) (P  0.05)
(Table 2), whereas equilibrium dissociation constants (Kd) were not significantly different among strains (P  0.05) (Fig.
4A; Table 2). The Europe-R strain also showed significant
differences relative to the other two strains when tested with
labeled Cry1Ab (Fig. 4B; Table 2). Kd was around 4-fold lower
(i.e., higher affinity) (P  0.05) and Rt was between 2- and
4-fold higher than in the other two strains (P  0.05), which
indicated an increase in overall affinity (Rt/Kd ratio) of at least
10-fold (Table 2). No significant changes in binding parameters
were observed among strains when using labeled Cry1Ac (Fig.
4C; Table 2).
Northern blotting. Results of Northern blotting experiments
performed with a probe specific to the O. nubilalis cadherin
gene are shown in Fig. 5. A single 5.2-kb mRNA band hybrid-
ized with the probe in all the strains tested (Fig. 5A). Signal
FIG. 2. Representative sensorgram of Cry1Ab interacting with
SUV from the O. nubilalis susceptible strain (Europe-S) and two
Cry1Ab-selected strains (Europe-R and RSTT-R).
TABLE 1. Cry1Ab kinetic parameters and equilibrium dissociation
constants from Cry1Ab-susceptible and -resistant European
corn borer, Ostrinia nubilalis, strains using real-time
analysis (Biacore 2000)a
Strain kon (M1 s1) (103) koff (s1) (104) Kd (nM)
Europe-S 10.7 
 0.3 a 3.7 
 0.4 a 35 
 3 a
Europe-R 9.7 
 0.3 b 5.9 
 0.5 a 61 
 6 b
RSTT-R 10.03 
 0.04 b 9.5 
 1.1 b 94 
 11 c
a Values are means 
 standard deviations from three replicates (three batches
of SUV). Means in a column that are followed by the same letter were not
statistically different (least significance difference test, P  0.05).
FIG. 3. Specific binding of 125I-labeled toxin to increasing concen-
trations of BBMV from O. nubilalis. (A) Cry1Aa; (B) Cry1Ab;
(C) Cry1Ac. Œ and solid line, Europe-S; F and dashed line, Europe-R;
■ and dotted line, RSTT-R.
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intensity for the cadherin-like transcripts was similar among
the selected and susceptible strains. RPS3 signal, used to stan-
dardize sample loading, was also very similar (Fig. 5B), sug-
gesting that the cadherin gene product in all the strains was
similarly expressed.
DISCUSSION
The key step in the specific action of Bt toxins is the binding
to brush border membrane receptors (38, 45, 49). It has also
been shown that alteration of binding of Bt toxins is associated
with high levels of resistance (for review, see references 8, 13,
14, 21, and 37). Aminopeptidase N and cadherin-like proteins,
among others, have been proposed as Bt toxin receptors in
insect midguts (15, 20, 48). However, resistance to Cry1A tox-
ins has been associated only with the cadherin receptor gene in
both H. virescens (10) and P. gossypiella (34).
Bt toxin resistance in O. nubilalis has thus far only been
characterized in a strain that was selected with Dipel. This
strain showed a broad spectrum of resistance to Bt protoxins,
being highly resistant to all Bt protoxins present in Dipel
(Cry1Aa, Cry1Ab, Cry1Ac, and Cry2Aa), cross-resistant to
Cry1Ba protoxin (27), and only marginally resistant to acti-
vated Cry1Ab (26). Resistance was associated with reduction
of a trypsin-like protease involved in activation of the Bt pro-
toxin form (26, 29), and no alteration in Cry1Ab and Cry1Ac
binding was found in the resistant insects (28). Because the
Dipel formulation contains multiple toxins, it is unclear
whether such a resistance mechanism would evolve in response
to selection from a single toxin.
In the present work, it was hypothesized that receptor bind-
ing differences would exist between susceptible (Europe-S) and
Cry1Ab-selected (Europe-R and RSTT-R) strains of O. nubi-
lalis. Higher resistance of the selected strains to activated
Cry1Ab compared to Cry1Ab protoxin (39, 40) and a narrow
spectrum of cross-resistance were observed in earlier studies
(39). Additionally, there were no differences in activities of
luminal gut proteases with either model substrates or with
protoxin and activated Cry1Ab toxin (40). Together these re-
sults suggest that altered toxin binding to midgut receptors
might be associated with resistance.
Using standard immunoblotting techniques, three proteins
were found to bind Cry1Ab in the susceptible strain (Europe-
S). Furthermore, the same proteins were recognized by the O.
nubilalis cadherin antiserum, suggesting that they belong to the
cadherin protein superfamily (9). Alternatively, the smaller
bands that were recognized by the cadherin antiserum might
represent degradation peptides or processed forms from the
220-kDa protein. Because the Europe-R strain exhibited a
similar profile but with drastically reduced signal intensity, the
results suggest that resistance in this strain is associated with a
reduced concentration of the cadherin receptor. In contrast,
the RSTT-R strain showed only a slight decrease in signal
TABLE 2. Binding parameters estimated from homologous
competition experiments performed with labeled Cry toxins and
BBMV from susceptible and resistant strains of O. nubilalisa
Strain Ligand Kd (mean 
 SD)(nM)
Rt (mean 
 SD)
(pmol/mg)b Rt/Kd
Europe-S Cry1Aa 3.28 
 0.02 1.8 
 0.2 0.55
Europe-R 4 
 3 0.2 
 0.1 0.05
RSTT-R 3.0 
 0.7 2.3 
 0.4 0.77
Europe-S Cry1Ab 10 
 4 3.6 
 0.9 0.36
Europe-R 2.37 
 0.05 13 
 3 5.5
RSTT-R 11.9 
 0.1 6.8 
 0.3 0.57
Europe-S Cry1Ac 5 
 1 23 
 2 4.6
Europe-R 5.0 
 0.8 49 
 9 9.8
RSTT-R 5 
 3 30 
 10 6.0
a Values are the means and standard deviations of at least two replicates.
b Rt is expressed in pmoles of binding sites per milligram of total vesicle
protein.
FIG. 4. Binding of 125I-labeled toxins to BBMV from O. nubilalis
strains at increasing concentrations of unlabeled competitor. (A) Cry1Aa;
(B) Cry1Ab; (C) Cry1Ac. Œ and solid line, Europe-S; F and dashed line,
Europe-R; ■ and dotted line, RSTT-R.
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intensity compared with the susceptible strain with both the
anticadherin antibody and with Cry1Ab.
Based on results from immunoblotting, we expected to find
a marked reduction in binding of Cry1Ab to SUV from the
Europe-R strain. Detailed analysis of binding kinetics using
SPR indicated only slight differences among strains. The RSTT-R
strain, which showed only minor differences in both the Cry1Ab
ligand blot and Western blot assays using the anticadherin anti-
body, exhibited greater differences in Cry1Ab binding relative to
the Europe-R strain. However, these minor differences appear
unlikely to completely explain the resistance to Cry1Ab associated
with this strain. It is worth noting that, in a previous study with a
P. xylostella Cry1A-resistant strain, a study carried out with SPR
did not show any major difference in binding of Cry1Ac (33),
while binding analysis using 125I-labeled Cry1Ac indicated a dras-
tic reduction of toxin binding (44).
Binding analysis with 125I-labeled Cry1Ab to BBMV from
the Europe-R strain showed an increase in the overall affinity
of this toxin with an almost fourfold increase in concentra-
tion of binding sites. However, when binding of 125I-labeled
Cry1Aa was tested, a 10-fold reduction in the concentration of
binding sites was found. No changes were observed using 125I-
labeled Cry1Ac. With the RSTT-R strain, no differences with
the Europe-S strain were found with either of the 125I-labeled
Cry1A toxins.
Similar results to those found in the Europe-R strain have
been reported for the YHD2 colony of H. virescens, in which
altered Cry1Aa binding was associated with resistance to
Cry1Ac and Cry1Ab, although differences in binding were de-
tected only for Cry1Aa (25). A mutation in the cadherin re-
ceptor gene has been associated with resistance in the YHD2
strain (10). There are other examples in which resistance to
Cry1A toxins has been associated with reduced binding of one
toxin without measurable effects on others. In P. gossypiella
strain AZP-R, resistance to Cry1A toxins was associated with
lack of binding of Cry1Ab but not of Cry1Aa or Cry1Ac (13).
This strain was shown to carry three mutant alleles of the
cadherin gene, which was shown to be linked to resistance to
Cry1A toxins (34). Other examples in which lack of binding of
just one Cry1A toxin has been associated with resistance to the
three Cry1A toxins have also been reported in P. xylostella (2,
14, 47). We hypothesize that the above examples reflect bind-
ing of some Cry1A toxins to BBMV proteins other than those
involved in the in vivo toxic action. It is well known that
Cry1Ac (but not Cry1Aa or Cry1Ab) has a high affinity for
GalNAc residues and that aminopeptidase-N contains such
residues (7, 16). Binding to these residues could mask a lack of
binding to other “effective” receptors.
It should be noted that differences in 125I-labeled Cry1Aa
binding in Europe-R were associated with differences in con-
centrations of binding sites rather than with affinity. This is in
agreement with the results obtained with the anticadherin an-
tibody and with Cry1Ab binding blot assays. However, the
lower concentration of the cadherin protein was not supported
by the results obtained on transcript abundance of the cadherin
gene, suggesting that the final reduction in cadherin protein
concentration must be due to posttranslational processing.
In combination, the results of the present work suggest that
differences in susceptibility to Cry1A toxins in the Europe-R
strain of O. nubilalis are associated with altered receptor bind-
ing, as shown by the reduced concentration of cadherin recep-
tors, although the precise nature of this mechanism is still
unclear. To our knowledge, this is the first time that an alter-
ation in the cadherin receptor has been shown in a Bt-resistant
strain at the protein level. The resistance alleles contributing to
altered receptor binding in the Europe-R strain must be
present in RSTT-R due to the mixed origin of the founder
insects in the latter. However, this mechanism was not clearly
observed in RSTT-R, suggesting that other factors may have a
more important contribution to resistance in this strain. Inher-
itance experiments with these strains have indicated that resis-
tance is associated with multiple loci and, therefore, suggest a
complex resistance mechanism (1). Receptor isolation and fur-
ther characterization will be important to clarify the differences
between the strains analyzed in this study.
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